Taken all together, the present studies reveled that the chronic oral administration of small-molecule Ga caused the selective leptin sensitization in the liver, resulting in significant attenuation of hepatosteatosis and hyperglycemia in obesity. This evidence concerns the gene LEP and obesity disorder.